HealthcareServices

Global Rheumatic Heart Disease Market Report 2026–2035: Key Forecasts and Growth Areas

March 2, 2026March 3, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the rheumatic heart disease market from 2026–2035 with trusted insights from The Business Research Company

How much is the Rheumatic Heart Disease Market valued at in 2026, and what valuation is forecast for 2030?

The rheumatic heart disease market size has experienced significant expansion in recent years. Projections indicate it will expand from $2.71 billion in 2025 to $2.88 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.1%. Historically, this growth has been driven by factors such as the widespread occurrence of untreated streptococcal infections, restricted access to initial healthcare services in developing areas, the long-standing impact of rheumatic fever, reliance on conventional clinical diagnosis techniques, and insufficient availability of sophisticated cardiac treatment.

The rheumatic heart disease market size is anticipated to undergo significant expansion over the next few years. It is projected to reach $3.6 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.8%. This growth during the forecast period can be attributed to heightened investments in public health screening programs, the increasing adoption of digital cardiac diagnostics, a growing awareness of the benefits of early intervention, the expansion of cardiac surgical infrastructure, and an increased focus on strategies for disease prevention. Prominent trends expected in the forecast period include a greater uptake of early diagnostic screening programs, the rising utilization of echocardiography and imaging tools, an evolving focus on preventive antibiotic therapies, the expansion of valve repair and replacement procedures, and enhanced monitoring for pediatric and adolescent patients.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23502&type=smp

What Drivers Are Influencing The Growth Of The Rheumatic Heart Disease Market?

The rising occurrence of strep throat is projected to fuel the expansion of the rheumatic heart disease market in the future. Strep throat is defined as a bacterial infection stemming from streptococcus pyogenes (group A streptococcus), resulting in throat inflammation and discomfort, frequently alongside fever, enlarged lymph nodes, and issues with swallowing. Growing antibiotic resistance makes streptococcal infections more challenging to treat effectively, contributing to extended periods of illness and increased community transmission rates. Rheumatic heart disease emerges as a chronic consequence of strep throat infections that are either left untreated or recur, thereby emphasizing the critical need for prompt diagnosis and treatment of streptococcal infections to avert serious heart damage. For example, data from April 2023, provided by the Centers for Disease Control and Prevention, a US-based government department, indicates that strep throat is responsible for approximately 5.2 million outpatient visits each year among people under 65 years old. These visits result in 2.8 million antibiotic prescriptions annually. Consequently, the expanding prevalence of strep throat is propelling the growth of the rheumatic heart disease market.

What Segments Are Included Within The Rheumatic Heart Disease Market?

The rheumatic heart disease market covered in this report is segmented –

1) By Type: Valve, Myocarditis, Pericarditis

2) By Age Group: Pediatric, Adolescent, Adult, Geriatric

3) By Application: Hospital, Diagnostic Centre, Research Centre

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Direct Sales

Subsegments:

1) By Valve: Mitral Valve Disease, Aortic Valve Disease, Tricuspid Valve Disease, Pulmonary Valve Disease

2) By Myocarditis: Acute Myocarditis, Chronic Myocarditis, Fulminant Myocarditis

3) By Pericarditis: Acute Pericarditis, Chronic Pericarditis, Constrictive Pericarditis, Effusive Pericarditis

Which Innovation Trends Are Advancing Developments Within The Rheumatic Heart Disease Market?

Leading companies operating in the rheumatic heart disease market are adopting a strategic partnership approach to develop innovative treatments and diagnoses. Strategic partnerships in the rheumatic heart disease (RHD) management consolidate resources and expertise to propel research and development, enhance diagnostic and therapeutic innovations, expand market presence, and accelerate commercialization. For instance, in July 2023, the World Heart Federation (WHF), a Switzerland-based non-governmental organization, collaborated with the Philips Foundation, a Netherlands-based nonprofit organization, to heighten awareness, improve medical training, and advance early detection of rheumatic heart disease (RHD) in the Asia-Pacific (APAC) region. Launched in the Philippines, this initiative aims to improve healthcare access for over half a million at-risk Filipino children by furnishing facilities with qualified professionals and cutting-edge diagnostic tools. This collaboration emphasizes a mutual commitment to fortifying healthcare infrastructure and ensuring timely intervention for RHD patients.

Who Are The Primary Competitors In The Global Rheumatic Heart Disease Market?

Major companies operating in the rheumatic heart disease market are Pfizer Inc., Merck And Co Inc., Bayer AG, Sanofi SA, AstraZeneca plc, Novartis AG, Abbott Laboratories, GlaxoSmithKline plc, Medtronic plc, Siemens Healthineers AG, Becton Dickinson And Company, GE HealthCare Technologies Inc., Boston Scientific Corporation, Terumo Corporation, Apollo Hospitals Enterprise Limited, Fortis Healthcare Limited, Medanta, Johnson And Johnson Services Inc., Roche Holding AG, Bristol Myers Squibb Company, Takeda Pharmaceutical Company Limited, Daiichi Sankyo Company, Boehringer Ingelheim International GmbH, Edwards Lifesciences Corporation

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/rheumatic-heart-disease-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Rheumatic Heart Disease Market?

North America was the largest region in the rheumatic heart disease market in 2025. The regions covered in the rheumatic heart disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Rheumatic Heart Disease Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=23502&type=smp

Browse Through More Reports Similar to the Global Rheumatic Heart Disease Market 2026, By The Business Research Company

Peripheral Arterial Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-arterial-disease-global-market-report

Heart Attack Diagnostic Market Report 2026

https://www.thebusinessresearchcompany.com/report/heart-attack-diagnostic-global-market-report

Peripheral Artery Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-artery-disease-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795